CNS - Intra-Cellular Therapies drops 2% prices $500M equity financing
2024-04-18 02:47:32 ET
More on Intra-Cellular Therapies
- Intra-Cellular: More Upside Possible Even After Positive MDD Treatment Data
- Intra-Cellular Therapies Is On Fire
- Intra-Cellular Therapies gains on meeting main goal in trial for its depression treatment
- Intra-Cellular files lawsuits challenging Caplyta generics